drugset / Trial / NCT05618314
Study of AT-527 in Subjects With Normal and Impaired Renal Function
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Study of AT-527 in Subjects with Normal and Impaired Renal Function
Timeline
- Start
- 2022-10-17
- Primary completion
- 2024-06-15
- Completion
- 2024-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bemnifosbuvir | Other / unclassified | — | — |
| Subject | Probenecid | Small molecule | — | — |